PPARα调节PAI-1活性的分子机理

批准号:
39970301
项目类别:
面上项目
资助金额:
13.0 万元
负责人:
叶平
依托单位:
学科分类:
H0214.动脉粥样硬化与动脉硬化
结题年份:
2002
批准年份:
1999
项目状态:
已结题
项目参与者:
尚延中、宋立功、胡晓晖、郝好杰、李琦
关键词:
国基评审专家1V1指导 中标率高出同行96.8%
结合最新热点,提供专业选题建议
深度指导申报书撰写,确保创新可行
指导项目中标800+,快速提高中标率
微信扫码咨询
中文摘要
本课题以FAs作为PPARa的激活物,以研究PPARa和相关的转录因子的作用为基点,探讨FAs激活PPARa对PAI-1活性的影响及其分子机理;同时研究PPARa或转录因子激活在高甘油三酯血⒃黾覲AI-1活性中的作用。
英文摘要
It is well known that high plasminogen activator inhibitor-1(PAI-1)level and activity, as the risk factors for atherosclerosis, are obviously associated with hypertriglyceridemia. The mechanism of the association remains imprecise. Feeding on fatty acids up-regulate level of PAI-1 and fatty acids can acivate peroxisome proliferator-activated receptors(PPARs). Therefore we hypothesized that PPARs might play a role in regulating gene transcription involved in linking hypertriglyceridemia and high PAI-1 levels and PAI-1 might be a PPARs target gene. We investigated the mechanism via diverse techniques of cell biology and molecular biology in human umbilical vein endothelial cells(HUVECs) and human hepatoblastome (HepG2)cells in vitro. Both in cultured HUVECs and HepG2 cells, polyunsaturated fatty acids augnent the expression of PAI-1 at mRNA and protein levels in a dose-dependent manner. However, the mRNA expressions of PPARs with their activators(e.g.fatty acids and prostaglandin J2) in both HUVECs and HepG2 cells were not changed compared with controls. We observed for the first time that PAI-1 transcriptional activity was signifivantly enhanced by PPARαplasmid co-transfection to ECV304 and polyunsaturated fatty acids enhanced the effects,but no change in PAI-1 transcriptional activity was observed when the expression of PPARγwas increased.Our results showed for the first time internationlly that hypertriglyceridemia affects the level of PAI-1 and PPARαinvolves in the regulating process at least in part,which is one of the molecular mechanism that hypertriglyceridemia affects the activity of fibrinolysis system clinically.
专著列表
科研奖励列表
会议论文列表
专利列表
基于miR-638对StarD10的调控探索其在HDL代谢中的表观遗传学机制
- 批准号:81270941
- 项目类别:面上项目
- 资助金额:70.0万元
- 批准年份:2012
- 负责人:叶平
- 依托单位:
PPARs信号转导途径介入心脏衰老及他汀干预的作用机制的实验研究
- 批准号:30872713
- 项目类别:面上项目
- 资助金额:33.0万元
- 批准年份:2008
- 负责人:叶平
- 依托单位:
不同的PPARα激活物影响PAI-1表达的机制探讨
- 批准号:30470717
- 项目类别:面上项目
- 资助金额:21.0万元
- 批准年份:2004
- 负责人:叶平
- 依托单位:
PPARs激活剂对实验性心力衰竭的作用及机制探讨
- 批准号:30270551
- 项目类别:面上项目
- 资助金额:19.0万元
- 批准年份:2002
- 负责人:叶平
- 依托单位:
国内基金
海外基金
